Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Srikripa Devarakonda's Stock Ratings
Truist Securities Analyst
Srikripa Devarakonda is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
19.6%
Smart Score
Overall Average Return Percentile
76th
Number of Ratings
87
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | SEPN | Buy Now | Septerna | $28.00 | 21.43% | → $34 | Initiates | → Buy | Get Alert | |
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | 35.39% | $80 → $116 | Maintains | Buy | Get Alert | |
| 12/09/2025 | TERN | Buy Now | Terns Pharma | $44.17 | 26.78% | $35 → $56 | Maintains | Buy | Get Alert | |
| 11/26/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -6.63% | $68 → $80 | Maintains | Buy | Get Alert | |
| 11/19/2025 | TERN | Buy Now | Terns Pharma | $44.17 | -20.76% | $28 → $35 | Maintains | Buy | Get Alert | |
| 11/19/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $555.55 | 15.2% | $580 → $640 | Maintains | Buy | Get Alert | |
| 11/04/2025 | TERN | Buy Now | Terns Pharma | $44.17 | -36.61% | $20 → $28 | Reiterates | Buy → Buy | Get Alert | |
| 10/29/2025 | INCY | Buy Now | Incyte | $99.08 | -6.14% | $79 → $93 | Reiterates | Hold → Hold | Get Alert | |
| 10/28/2025 | PTGX | Buy Now | Protagonist Therapeutics | $94.41 | -6.79% | $76 → $88 | Maintains | Buy | Get Alert | |
| 10/20/2025 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -2.74% | $54 → $44 | Maintains | Buy | Get Alert | |
| 10/15/2025 | VTRS | Buy Now | Viatris | $11.61 | 29.2% | → $15 | Initiates | → Buy | Get Alert | |
| 10/15/2025 | MBX | Buy Now | MBX Biosciences | $28.10 | 77.94% | → $50 | Initiates | → Buy | Get Alert | |
| 10/15/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $555.55 | 4.4% | → $580 | Initiates | → Buy | Get Alert | |
| 10/15/2025 | TERN | Buy Now | Terns Pharma | $44.17 | -54.72% | → $20 | Initiates | → Buy | Get Alert | |
| 09/30/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -20.63% | $53 → $68 | Maintains | Buy | Get Alert | |
| 08/11/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 7.89% | $940 → $812 | Maintains | Buy | Get Alert | |
| 07/30/2025 | INCY | Buy Now | Incyte | $99.08 | -20.27% | $73 → $79 | Maintains | Hold | Get Alert | |
| 05/27/2025 | INCY | Buy Now | Incyte | $99.08 | -26.32% | $72 → $73 | Maintains | Hold | Get Alert | |
| 05/05/2025 | ARVN | Buy Now | Arvinas | $12.28 | -10.42% | $21 → $11 | Downgrade | Buy → Hold | Get Alert | |
| 04/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 24.9% | $975 → $940 | Maintains | Buy | Get Alert | |
| 04/29/2025 | BIIB | Buy Now | Biogen | $177.62 | 12.04% | $210 → $199 | Maintains | Buy | Get Alert | |
| 04/23/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 29.55% | $1004 → $975 | Maintains | Buy | Get Alert | |
| 04/09/2025 | KROS | Buy Now | Keros Therapeutics | $21.20 | 17.92% | $43 → $25 | Maintains | Buy | Get Alert | |
| 03/18/2025 | INCY | Buy Now | Incyte | $99.08 | -27.33% | $74 → $72 | Maintains | Hold | Get Alert | |
| 03/11/2025 | PTGX | Buy Now | Protagonist Therapeutics | $94.41 | -19.5% | $60 → $76 | Maintains | Buy | Get Alert | |
| 02/13/2025 | BIIB | Buy Now | Biogen | $177.62 | 18.23% | $220 → $210 | Maintains | Buy | Get Alert | |
| 02/03/2025 | LLY | Buy Now | Eli Lilly | $1.07K | -2.9% | $1029 → $1038 | Maintains | Buy | Get Alert | |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $227.97 | -4.81% | $211 → $217 | Maintains | Buy | Get Alert | |
| 01/08/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 33.4% | $1126 → $1004 | Maintains | Buy | Get Alert | |
| 01/08/2025 | BIIB | Buy Now | Biogen | $177.62 | 23.86% | $302 → $220 | Maintains | Buy | Get Alert | |
| 01/08/2025 | ABBV | Buy Now | AbbVie | $227.97 | -7.44% | $215 → $211 | Maintains | Buy | Get Alert | |
| 12/23/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 102.83% | $100 → $43 | Maintains | Buy | Get Alert | |
| 12/18/2024 | PFE | Buy Now | Pfizer | $26.47 | 20.89% | $36 → $32 | Maintains | Buy | Get Alert | |
| 11/27/2024 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 106.02% | $33 → $50 | Maintains | Buy | Get Alert | |
| 11/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -0.53% | $36 → $45 | Maintains | Buy | Get Alert | |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 49.61% | $1137 → $1126 | Maintains | Buy | Get Alert | |
| 11/01/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -38.14% | $54 → $53 | Reiterates | Buy → Buy | Get Alert | |
| 10/16/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 51.07% | $1200 → $1137 | Maintains | Buy | Get Alert | |
| 10/10/2024 | LLY | Buy Now | Eli Lilly | $1.07K | -3.37% | $1000 → $1033 | Maintains | Buy | Get Alert | |
| 10/10/2024 | ABBV | Buy Now | AbbVie | $227.97 | -5.69% | $210 → $215 | Maintains | Buy | Get Alert | |
| 09/27/2024 | BMEA | Buy Now | Biomea Fusion | $1.35 | 3900% | $54 → $54 | Upgrade | Hold → Buy | Get Alert | |
| 09/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 59.44% | $1200 → $1200 | Reiterates | Buy → Buy | Get Alert | |
| 09/19/2024 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 35.97% | $25 → $33 | Maintains | Buy | Get Alert | |
| 09/18/2024 | INCY | Buy Now | Incyte | $99.08 | -25.31% | $83 → $74 | Downgrade | Buy → Hold | Get Alert | |
| 09/09/2024 | PTGX | Buy Now | Protagonist Therapeutics | $94.41 | -36.45% | → $60 | Initiates | → Buy | Get Alert | |
| 08/13/2024 | VSTM | Buy Now | Verastem | $9.34 | 60.6% | $18 → $15 | Maintains | Buy | Get Alert | |
| 08/05/2024 | BIIB | Buy Now | Biogen | $177.62 | 70.03% | $340 → $302 | Reiterates | Buy → Buy | Get Alert | |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 59.44% | $1135 → $1200 | Reiterates | Buy → Buy | Get Alert | |
| 07/31/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.25 | 87.01% | → $36 | Initiates | → Buy | Get Alert | |
| 07/08/2024 | VSTM | Buy Now | Verastem | $9.34 | 92.72% | $34 → $18 | Maintains | Buy | Get Alert | |
| 06/25/2024 | LLY | Buy Now | Eli Lilly and Co | $1.07K | -6.45% | $892 → $1000 | Reiterates | Buy → Buy | Get Alert | |
| 06/18/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 371.7% | $100 → $100 | Maintains | Buy | Get Alert | |
| 05/29/2024 | CYTK | Buy Now | Cytokinetics | $63.00 | 11.11% | $86 → $70 | Maintains | Buy | Get Alert | |
| 05/01/2024 | INCY | Buy Now | Incyte | $99.08 | -16.23% | $84 → $83 | Reiterates | Buy → Buy | Get Alert | |
| 05/01/2024 | LLY | Buy Now | Eli Lilly and Co | $1.07K | -16.56% | $850 → $892 | Maintains | Buy | Get Alert | |
| 04/17/2024 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 3.01% | $25 → $25 | Maintains | Buy | Get Alert | |
| 04/08/2024 | CYTK | Buy Now | Cytokinetics | $63.00 | 36.51% | $86 → $86 | Reiterates | Buy → Buy | Get Alert | |
| 04/03/2024 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -55.79% | $20 → $20 | Reiterates | Buy → Buy | Get Alert | |
| 03/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -55.79% | → $20 | Reiterates | Buy → Buy | Get Alert | |
| 03/13/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 371.7% | → $100 | Reiterates | Buy → Buy | Get Alert | |
| 03/01/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -36.97% | $41 → $54 | Maintains | Buy | Get Alert | |
| 02/14/2024 | INCY | Buy Now | Incyte | $99.08 | -15.22% | $91 → $84 | Maintains | Buy | Get Alert | |
| 12/28/2023 | CYTK | Buy Now | Cytokinetics | $63.00 | 36.51% | $60 → $86 | Maintains | Buy | Get Alert | |
| 11/29/2023 | INCY | Buy Now | Incyte | $99.08 | -8.16% | → $91 | Reiterates | Buy → Buy | Get Alert | |
| 11/15/2023 | VSTM | Buy Now | Verastem | $9.34 | 264.03% | $39 → $34 | Maintains | Buy | Get Alert | |
| 09/21/2023 | INCY | Buy Now | Incyte | $99.08 | -8.16% | → $91 | Reiterates | Buy → Buy | Get Alert | |
| 08/11/2023 | AFMD | Buy Now | Affimed | — | — | $8 → $6 | Maintains | Buy | Get Alert | |
| 08/02/2023 | INCY | Buy Now | Incyte | $99.08 | -8.16% | $100 → $91 | Maintains | Buy | Get Alert | |
| 07/11/2023 | VSTM | Buy Now | Verastem | $9.34 | 317.56% | $60 → $39 | Maintains | Buy | Get Alert | |
| 06/30/2023 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -41.64% | → $50 | Initiates | → Buy | Get Alert | |
| 06/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 3.01% | → $25 | Reiterates | Buy → Buy | Get Alert | |
| 06/27/2023 | VSTM | Buy Now | Verastem | $9.34 | 542.4% | $60 → $60 | Reiterates | Buy → Buy | Get Alert | |
| 06/27/2023 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 3.01% | → $25 | Reiterates | Buy → Buy | Get Alert | |
| 06/23/2023 | VSTM | Buy Now | Verastem | $9.34 | 542.4% | → $60 | Reiterates | Buy → Buy | Get Alert | |
| 05/01/2023 | EWTX | Buy Now | Edgewise Therapeutics | $24.27 | 3.01% | → $25 | Initiates | → Buy | Get Alert | |
| 03/20/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | → $38 | Downgrade | Buy → Hold | Get Alert | |
| 02/16/2023 | INCY | Buy Now | Incyte | $99.08 | 0.93% | $95 → $100 | Maintains | Buy | Get Alert | |
| 12/20/2022 | CYTK | Buy Now | Cytokinetics | $63.00 | -4.76% | → $60 | Initiates | → Buy | Get Alert | |
| 10/18/2022 | KROS | Buy Now | Keros Therapeutics | $21.20 | 371.7% | → $100 | Initiates | → Buy | Get Alert | |
| 07/12/2022 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -55.79% | → $20 | Initiates | → Buy | Get Alert | |
| 06/22/2022 | NMTR | Buy Now | 9 Meters Biopharma | — | — | $5 → $2 | Maintains | Buy | Get Alert | |
| 03/09/2022 | VSTM | Buy Now | Verastem | $9.34 | -35.76% | → $6 | Initiates | → Buy | Get Alert | |
| 10/21/2021 | AFMD | Buy Now | Affimed | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 06/03/2021 | CNST | Buy Now | Constellation | — | — | $50 → $34 | Downgrade | Buy → Hold | Get Alert | |
| 01/07/2021 | INCY | Buy Now | Incyte | $99.08 | 21.11% | → $120 | Initiates | → Buy | Get Alert | |
| 06/30/2020 | NMTR | Buy Now | 9 Meters Biopharma | — | — | → $5 | Initiates | → Buy | Get Alert | |
| 02/13/2020 | CNST | Buy Now | Constellation | — | — | → $50 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved